Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current EHC market cap is 10.49B. The company's latest EPS is USD 3.4938 and P/E is 29.70.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.21B | 1.25B | 1.32B | 1.3B | 1.35B |
| Operating Income | 147.9M | 190.8M | 208.2M | 217M | 181.6M |
| Net Income | 85.3M | 87.6M | 112.5M | 114.1M | 108.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.61B | 4.64B | 5.12B | 4.35B | 4.8B |
| Operating Income | 699.2M | 648.5M | 810.5M | 633.1M | 735M |
| Net Income | 358.7M | 284.2M | 412.2M | 271M | 352M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.96B | 6.1B | 6.23B | 6.39B | 6.46B |
| Total Liabilities | 3.78B | 3.81B | 3.83B | 3.86B | 3.73B |
| Total Equity | 2.15B | 2.26B | 2.36B | 2.48B | 2.67B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.08B | 6.45B | 6.86B | 5.64B | 6.1B |
| Total Liabilities | 4.15B | 4.44B | 4.47B | 3.77B | 3.81B |
| Total Equity | 1.69B | 1.97B | 2.36B | 1.83B | 2.26B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 649.8M | 850.8M | 238.8M | 456.2M | 724M |
| Investing | -394.7M | -602.8M | -129.7M | -288.1M | -449.6M |
| Financing | -167.3M | -197.2M | -40.6M | -90.2M | -179.7M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 635.3M | 704.7M | 715.8M | 705.8M | 850.8M |
| Investing | -657.4M | -407.5M | -666.3M | -627M | -602.8M |
| Financing | 48.2M | -145.9M | -240.1M | -145.7M | -197.2M |
| Market Cap | 10.49B |
| Price to Earnings Ratio | 29.70 |
| Price to Sales Ratio | 2.18 |
| Price to Cash Ratio | 151.29 |
| Price to Book Ratio | 4.55 |
| Dividend Yield | 0.65% |
| Shares Outstanding | 100.75M |
| Average Volume (1 week) | 692.81k |
| Average Volume (1 Month) | 704.85k |
| 52 Week Change | 57.78% |
| 52 Week High | 104.55 |
| 52 Week Low | 63.775 |
| Spread (Intraday) | 0.34 (0.33%) |
| Company Name | Encompass Health Corporation |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.encompasshealth.com |
| Industry | hospitals (8060) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
